ALB vs NXL · rev $1.74B vs rev $301.6K
Albemarle Corp (ALB) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
ALB currently screens at market cap $8.00B. NXL currently screens at market cap $8.5M.
Not investment advice. Open the ALB and NXL stock pages for the full models.
Not investment advice.